Tracking babies born to moms on lupus drug
NCT ID NCT06795893
Summary
This study aims to understand the safety of the lupus medication anifrolumab during pregnancy. It will follow about 240 women with lupus who took the drug while pregnant, tracking their health and their babies' health for up to a year after birth. The main goal is to check for any birth defects or other problems that might be linked to the medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Reseach Facility
RECRUITINGSödertälje, Sweden
Conditions
Explore the condition pages connected to this study.